MedPath

The effect of taking green tea on patients with Alzheimer's

Phase 2
Conditions
Alzheimer.
Alzheimer disease with late onset
Registration Number
IRCT201612063684N8
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Mini-mental state examination score between 0-10; rejection of other causes of dementia by performing MRI, CT scans and laboratory tests (TSH, T3, T4, CBC / DIFF, BUN / CR, FBS, LFT and ESR) .
exclusion criteria: green tea allergy; inflammatory and infectious diseases such as hepatitis, anemia, and diabetes; treated with antioxidant agents such as vitamin E, C, A and folic.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DPPH free radical level. Timepoint: Before the intervention and two months after the end of the intervention. Method of measurement: according to percent by using the Brand-Williams method.;Trace elements zinc. Timepoint: Before the intervention and two months after the end of the intervention. Method of measurement: In micrograms per deciliter using colorimetric method.;Trace elements iron. Timepoint: Before the intervention and two months after the end of the intervention. Method of measurement: In micrograms per deciliter using colorimetric method.;Trace elements copper. Timepoint: Before the intervention and two months after the end of the intervention. Method of measurement: In micrograms per deciliter using colorimetric method.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath